Indoco Remedies Limited

₹215.06As of Sun 8 Nov 2026, 12:00 UTC
NSE:INDOCOHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR (2.39%)
Div yield 0.09%
ROE 3.19%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.66
PE TTM 62.81
TSR TTM (22.89%)
Mkt cap ₹19.85B
ROIC 1.25%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹263
22.25%
(84.27%)
Hold 4|8|1|8|3
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
3.40
3.60
3.89
4.21
9.25%
21.36%
28.78%
24.98%
Revenue₹B
1.061
1.032
1.049
1.049
4.04%
1.86%
2.15%
3.60%
Peers (US$211.4M)
Cap (US$)
PE
213.2M
14.37x
206.5M
15.78x
Capital
TTM
5Y
10Y
Leveragex
1.767
(1.980)
(1.805)
EBIT/Intx
0.319
0.165
0.165
Own earn%
(181.36)
308.20
260.04
Sh yield%
44.34
39.40
39.65
Owners
Insiders/Inst%
4.99
40.68
Short interest%
1.82
SBC / revenue%
1.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
18–25
$1 testx
1.2
Incr. ROIC%
2